|
Volumn 16, Issue 5, 2010, Pages 364-366
|
Clinical features of Proteus mirabilis pneumonia
|
Author keywords
Hospital acquired infection; Pneumonia; Proteus mirabilis
|
Indexed keywords
AMIKACIN;
AMPICILLIN;
AZTREONAM;
CEFAZOLIN;
CEFEPIME;
CEFOTIAM;
CEFTAZIDIME;
CILASTATIN PLUS IMIPENEM;
LEVOFLOXACIN;
MEROPENEM;
PIPERACILLIN;
SULPERAZON;
SULTAMICILLIN;
ADULT;
AGED;
ANTIBIOTIC RESISTANCE;
ARTICLE;
ASPIRATION PNEUMONIA;
BACTERIAL PNEUMONIA;
BACTERIAL STRAIN;
BACTERIUM DETECTION;
CAUSE OF DEATH;
CEREBROVASCULAR DISEASE;
CLINICAL ARTICLE;
CLINICAL EFFECTIVENESS;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
ERADICATION THERAPY;
FEMALE;
HOSPITAL INFECTION;
HUMAN;
JAPAN;
MALE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
NONHUMAN;
PERSISTENT INFECTION;
PROGNOSIS;
PROTEUS INFECTION;
PROTEUS MIRABILIS;
RETROSPECTIVE STUDY;
URINARY TRACT INFECTION;
|
EID: 78149416502
PISSN: 1341321X
EISSN: None
Source Type: Journal
DOI: 10.1007/s10156-010-0059-3 Document Type: Article |
Times cited : (16)
|
References (7)
|